Who can use DIFICID(Fidaxomicin)?

1. Indicated for the treatment of Clostridium difficile-associated diarrhea (CDAD) in adult and pediatric patients aged 6 months and older.

2. To reduce the development of drug-resistant bacteria and maintain the effectiveness of fidaxomicin and other antibacterial agents, fidaxomicin should only be used to treat infections that are proven or strongly suspected to be caused by Clostridium difficile.

Related Columns

Fidaxomicin(DIFICID)

Indicated for the treatment of Clostridium difficile-associated diarrhea (CDAD)...

WeChat Scan
Free Inquiry

What Kind of Drug Is Dificid (Fidaxomicin)?

Dificid (fidaxomicin) is a new-generation macrolide antibacterial agent. It plays an important role in the treatment of Clostridioides difficile infections through a unique targeted mechanism of actio...

What Kind of Drug Is Dificid (Fidaxomicin)?

Dificid (fidaxomicin) is a macrolide antibacterial drug developed by Merck & Co., Inc. It was approved for marketing by the U.S. FDA in 2011. As a narrow-spectrum antibacterial agent, fidaxomicin ...

Fidaxomicin instructions: effects and efficacy

Fidaxomicin(DIFICID) is a narrow-spectrum macrolide antibiotic specifically used to treat Clostridium difficile-associated diarrhea (CDAD). It precisely inhibits the growth of pathogens and reduc...

What diseases can Fidaxomicin treat?

Fidaxomicin was officially approved by the U.S. Food and Drug Administration (FDA) on May 27, 2011 and was launched in the U.S. market. So far, the drug has not been launched in China and has not...